Spots Global Cancer Trial Database for cancer,
Every month we try and update this database with for cancer, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer | NCT00504790 | Cancer | GSK923295 | 18 Years - | GlaxoSmithKline | |
| Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer | NCT00426504 | Cancer | Radiotherapy | 18 Years - | Ottawa Hospital Research Institute | |
| Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer | NCT00504790 | Cancer | GSK923295 | 18 Years - | GlaxoSmithKline | |
| Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy | NCT00350688 | Bladder Cancer | Helical tomothe... | 18 Years - | Ottawa Hospital Research Institute | |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 | NCT00733031 | Cancer, Solid Tumors Advanced Solid ... | AZD6918 gemcitabine pemetrexed | 18 Years - | AstraZeneca | |
| To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours | NCT01900028 | Solid Tumours | Pharmacokinetic... Olaparib tablet... Itraconazole | 18 Years - 130 Years | AstraZeneca | |
| Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment | NCT01894243 | Solid Tumours | Olaparib tablet... | 18 Years - 130 Years | AstraZeneca | |
| Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer | NCT00426504 | Cancer | Radiotherapy | 18 Years - | Ottawa Hospital Research Institute | |
| Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function | NCT01894256 | Solid Tumours | Olaparib tablet... | 18 Years - 75 Years | AstraZeneca | |
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer | NCT01379534 | Solid Tumors an... Endometrial Can... Second-line Tre... VEGF | TKI258 | 18 Years - | Novartis | |
| Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment | NCT01894243 | Solid Tumours | Olaparib tablet... | 18 Years - 130 Years | AstraZeneca | |
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer | NCT01379534 | Solid Tumors an... Endometrial Can... Second-line Tre... VEGF | TKI258 | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
